sorbitol has been researched along with paclitaxel in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kolodgie, FD; Ladich, E; Naisbitt, S; Nakano, M; Otsuka, F; Pacheco, E; Rousselle, S; Virmani, R; Yazdani, SK | 1 |
| Bosiers, M; Duda, S; Krankenberg, H; Naisbitt, S; Ricke, J; Rosenfield, K; Scheinert, D; Tepe, G; Zeller, T | 1 |
| Chen, Q; Huang, B; Mi, Y; Shan, Y; Shen, D; Shen, Y; Webster, TJ; Yu, G | 1 |
1 review(s) available for sorbitol and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for sorbitol and paclitaxel
| Article | Year |
|---|---|
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Drug Carriers; Equipment Design; Europe; Female; Femoral Artery; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Polysorbates; Popliteal Artery; Radiography; Secondary Prevention; Sorbitol; Time Factors; Treatment Outcome; Vascular Access Devices | 2014 |
5 other study(ies) available for sorbitol and paclitaxel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Equipment Design; Femoral Artery; Models, Animal; Paclitaxel; Polysorbates; Punctures; Sorbitol; Sus scrofa; Vascular Access Devices; Wound Healing | 2014 |
Macrophage escape by cholesterol-polyoxyethylene sorbitol oleate micelles for pulmonary delivery.
Topics: A549 Cells; Cholesterol; Drug Carriers; Humans; Lung; Macrophages; Micelles; Oleic Acid; Paclitaxel; Particle Size; Polyethylene Glycols; Sorbitol | 2020 |